We are live on ! Find out more
DCM

Driehaus Capital Management Portfolio holdings

AUM $17.3B
1-Year Est. Return 211.34%
This Fund
S&P 500
This Quarter Est. Return
+18.99%
1 Year Est. Return
+211.34%
3 Year Est. Return
+939.3%
5 Year Est. Return
+2,115.56%
10 Year Est. Return
+44,753.22%
AUM
$13.6B
AUM Growth
-$1.12B
Cap. Flow
-$2.17B
Cap. Flow %
-15.96%
Top 10 Hldgs %
16.77%
Holding
490
New
86
Increased
91
Reduced
173
Closed
135
Avg Time Held
4.1 quarters
Top 10 Avg Time Held
7.8 quarters
Top 20 Avg Time Held
4.7 quarters

Top Buys

Rank Stock Value
1
YUMC icon
Yum China
YUMC
+$94.8M
2
FN icon
Fabrinet
FN
+$76.3M
3
CAVA icon
CAVA Group
CAVA
+$61.7M
4
MTDR icon
Matador Resources
MTDR
+$59.6M
5
CGON icon
CG Oncology
CGON
+$56.6M

Top Sells

Rank Stock Value
1
TSM icon
TSMC
TSM
+$309M
2
HDB icon
HDFC Bank
HDB
+$136M
3
PI icon
Impinj
PI
+$128M
4
WFRD icon
Weatherford International
WFRD
+$108M
5
EMBJ icon
Embraer S.A. ADS
EMBJ
+$102M

Sector Composition

Rank Sector Weight
1 Healthcare 27.35%
2 Industrials 22.32%
3 Technology 17.87%
4 Consumer Discretionary 7.86%
5 Energy 7.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
TSM icon
1
TSMC
TSM
$2.32T
$427M 3.14%
1,264,890
-898,674
-42% -$309M
2013 Q2
51 quarters
PRAX icon
2
Praxis Precision Medicines
PRAX
$7.03B
$306M 2.25%
949,225
+16,164
+2% +$5M
2024 Q1
8 quarters
XENE icon
3
Xenon Pharmaceuticals
XENE
$3.48B
$261M 1.92%
4,491,653
-47,038
-1% -$2.17M
2020 Q1
24 quarters
CRNX icon
4
DELISTED
Crinetics Pharmaceuticals
CRNX
$232M 1.71%
6,395,922
+8,182
+0.1% +$365K
2020 Q2
23 quarters
PL icon
5
Planet Labs
PL
$5.92B
$221M 1.63%
7,918,693
-592,927
-7% -$15.2M
2025 Q2
3 quarters
FN icon
6
Fabrinet
FN
$16.2B
$204M 1.5%
391,081
+150,103
+62% +$76.3M
2025 Q2
3 quarters
APGE icon
7
DELISTED
Apogee Therapeutics
APGE
$162M 1.19%
1,920,800
-262,904
-12% -$19.1M
2023 Q3
10 quarters
LITE icon
8
Lumentum
LITE
$89.2B
$161M 1.18%
228,995
-112,053
-33% -$61.6M
2025 Q2
3 quarters
CW icon
9
Curtiss-Wright
CW
$18.8B
$154M 1.13%
225,759
-3,944
-2% -$2.62M
2022 Q1
16 quarters
BAP icon
10
Credicorp
BAP
$30.4B
$153M 1.12%
450,730
-21,314
-5% -$7.14M
2024 Q1
8 quarters
FTAI icon
11
FTAI Aviation
FTAI
$17B
$142M 1.04%
579,521
-121,004
-17% -$32M
2023 Q1
12 quarters
EWTX icon
12
Edgewise Therapeutics
EWTX
$4.21B
$141M 1.04%
4,477,942
+286,749
+7% +$8.27M
2023 Q4
9 quarters
GH icon
13
Guardant Health
GH
$21.3B
$141M 1.04%
1,524,282
-618,911
-29% -$62.1M
2025 Q1
4 quarters
SYRE icon
14
Spyre Therapeutics
SYRE
$8B
$141M 1.03%
2,790,785
-91,635
-3% -$3.45M
2023 Q2
11 quarters
IDCC icon
15
InterDigital
IDCC
$8.6B
$126M 0.93%
417,727
+42,553
+11% +$14.5M
2025 Q2
3 quarters
NXT icon
16
Nextpower Inc. Common Stock
NXT
$13B
$125M 0.92%
1,037,551
+237,813
+30% +$26.3M
2025 Q1
4 quarters
CRS icon
17
Carpenter Technology
CRS
$18.9B
$124M 0.91%
315,457
-87,839
-22% -$32M
2024 Q3
6 quarters
COHR icon
18
Coherent
COHR
$56.1B
$123M 0.9%
516,229
+68,284
+15% +$15.6M
2024 Q1
8 quarters
BE icon
19
Bloom Energy
BE
$76.9B
$115M 0.85%
849,801
+334,320
+65% +$49.1M
2025 Q3
2 quarters
UEC icon
20
Uranium Energy
UEC
$4.41B
$113M 0.83%
8,334,245
-777,827
-9% -$12M
2022 Q2
15 quarters
DFTX icon
21
Definium Therapeutics
DFTX
$4.73B
$112M 0.82%
5,911,889
-625,313
-10% -$10.6M
2024 Q1
8 quarters
IBN icon
22
ICICI Bank
IBN
$101B
$110M 0.81%
4,256,860
+193,408
+5% +$5.67M
2016 Q4
37 quarters
CCJ icon
23
Cameco
CCJ
$37.8B
$110M 0.81%
1,012,600
-510,038
-33% -$58.4M
2021 Q3
18 quarters
MOD icon
24
Modine Manufacturing
MOD
$9.42B
$107M 0.79%
494,734
+14,342
+3% +$2.7M
2022 Q4
13 quarters
SEPN icon
25
Septerna Inc
SEPN
$1.75B
$106M 0.78%
4,395,572
-413,898
-9% -$10.9M
2024 Q4
5 quarters
1
2 3 4 5

Similar funds

WA
Waverly Advisors Birmingham, Alabama $17.2B AUM 24.89% 1-Year Est. Return
EPFB
Employees Provident Fund Board Shah Alam, Malaysia $17.4B AUM 49.08% 1-Year Est. Return
LCOV
London Company of Virginia Richmond, Virginia $17.5B AUM 29.92% 1-Year Est. Return
TI
Trexquant Investment Stamford, Connecticut $17B AUM 39.66% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
AT
AMF Tjänstepension Stockholm, Sweden $16.9B AUM 36.16% 1-Year Est. Return
FCAS
First Command Advisory Services Fort Worth, Texas $16.8B AUM 23.38% 1-Year Est. Return
AI
Advent International Boston, Massachusetts $17.7B AUM 5.23% 1-Year Est. Return

Driehaus Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Driehaus Capital Management held 490 positions worth $13.6B, down 7.6% from $14.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Driehaus Capital Management withdrew a net $2.17B in Q1 2026, closing 135 positions and reducing 173 holdings. Its most notable exit was HDFC Bank, an estimated $136M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 29% a quarter earlier, followed by Industrials and Technology.

Against the trend, Driehaus Capital Management opened a new position in Yum China worth $89.3M.

  • Driehaus Capital Management's largest Q1 2026 buy was Yum China: 1,831,286 shares worth $89.3M.
  • Driehaus Capital Management added most to Fabrinet in Q1 2026, an estimated $76.3M increase.
  • Driehaus Capital Management's biggest Q1 2026 reduction was TSMC, cutting an estimated $309M.
  • Driehaus Capital Management fully exited HDFC Bank in Q1 2026, selling an estimated $136M.
  • Driehaus Capital Management's ten largest holdings make up 17% of its $13.6B portfolio in Q1 2026.
  • Driehaus Capital Management opened 86 new positions and closed 135 in Q1 2026.
  • Driehaus Capital Management's portfolio value fell 7.6% quarter-over-quarter to $13.6B.

Based on Driehaus Capital Management's 13F filing for Q1 2026, filed 15 May 2026.